Parametric Portfolio Associates’s Enanta Pharmaceuticals ENTA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $5.69M | Sell |
79,959
-10,303
| -11% | -$733K | ﹤0.01% | 1760 |
|
2021
Q4 | $6.75M | Buy |
90,262
+11,837
| +15% | +$885K | ﹤0.01% | 1658 |
|
2021
Q3 | $4.46M | Buy |
78,425
+16,639
| +27% | +$945K | ﹤0.01% | 1912 |
|
2021
Q2 | $2.72M | Sell |
61,786
-44,756
| -42% | -$1.97M | ﹤0.01% | 2256 |
|
2021
Q1 | $5.26M | Buy |
106,542
+55,936
| +111% | +$2.76M | ﹤0.01% | 2130 |
|
2020
Q4 | $2.13M | Buy |
50,606
+2,780
| +6% | +$117K | ﹤0.01% | 2610 |
|
2020
Q3 | $2.19M | Buy |
47,826
+12,055
| +34% | +$552K | ﹤0.01% | 2461 |
|
2020
Q2 | $1.8M | Sell |
35,771
-394
| -1% | -$19.8K | ﹤0.01% | 2561 |
|
2020
Q1 | $1.86M | Buy |
36,165
+9,657
| +36% | +$497K | ﹤0.01% | 2426 |
|
2019
Q4 | $1.64M | Sell |
26,508
-3,543
| -12% | -$219K | ﹤0.01% | 2816 |
|
2019
Q3 | $1.81M | Buy |
30,051
+508
| +2% | +$30.5K | ﹤0.01% | 2694 |
|
2019
Q2 | $2.49M | Sell |
29,543
-2,489
| -8% | -$210K | ﹤0.01% | 2519 |
|
2019
Q1 | $3.06M | Sell |
32,032
-3,165
| -9% | -$302K | ﹤0.01% | 2359 |
|
2018
Q4 | $2.49M | Buy |
35,197
+5,860
| +20% | +$415K | ﹤0.01% | 2432 |
|
2018
Q3 | $2.51M | Sell |
29,337
-12,009
| -29% | -$1.03M | ﹤0.01% | 2552 |
|
2018
Q2 | $4.79M | Buy |
41,346
+9,388
| +29% | +$1.09M | ﹤0.01% | 2000 |
|
2018
Q1 | $2.59M | Buy |
31,958
+8,172
| +34% | +$661K | ﹤0.01% | 2436 |
|
2017
Q4 | $1.4M | Buy |
23,786
+7,163
| +43% | +$420K | ﹤0.01% | 2839 |
|
2017
Q3 | $778K | Buy |
16,623
+3,847
| +30% | +$180K | ﹤0.01% | 3172 |
|
2017
Q2 | $460K | Buy |
12,776
+922
| +8% | +$33.2K | ﹤0.01% | 3408 |
|
2017
Q1 | $365K | Buy |
11,854
+1,989
| +20% | +$61.2K | ﹤0.01% | 3351 |
|
2016
Q4 | $330K | Sell |
9,865
-1,764
| -15% | -$59K | ﹤0.01% | 3376 |
|
2016
Q3 | $309K | Sell |
11,629
-4,545
| -28% | -$121K | ﹤0.01% | 3404 |
|
2016
Q2 | $357K | Sell |
16,174
-6,705
| -29% | -$148K | ﹤0.01% | 3371 |
|
2016
Q1 | $672K | Buy |
22,879
+5,631
| +33% | +$165K | ﹤0.01% | 3171 |
|
2015
Q4 | $570K | Buy |
17,248
+331
| +2% | +$10.9K | ﹤0.01% | 3158 |
|
2015
Q3 | $611K | Sell |
16,917
-2,287
| -12% | -$82.6K | ﹤0.01% | 2616 |
|
2015
Q2 | $864K | Buy |
19,204
+6,076
| +46% | +$273K | ﹤0.01% | 2907 |
|
2015
Q1 | $402K | Sell |
13,128
-1,508
| -10% | -$46.2K | ﹤0.01% | 3400 |
|
2014
Q4 | $744K | Sell |
14,636
-31,177
| -68% | -$1.58M | ﹤0.01% | 3006 |
|
2014
Q3 | $1.81M | Buy |
45,813
+39,351
| +609% | +$1.56M | ﹤0.01% | 2173 |
|
2014
Q2 | $278K | Buy |
+6,462
| New | +$278K | ﹤0.01% | 3559 |
|